You have 9 free searches left this month | for more free features.

City

Beijing (1)

Guangzhou (1)

Shenyang (1)

Condition

COPD Patients (1)

Coronavirus Infections (1)

Influenza (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 4 (2)

phase 3 (1)

Sponsor

Capital Medical University (1)

Guangzhou 8th People's Hospital (1)

Shengjing Hospital (1)

Collaborator

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (1)

Peking University (1)

University of Oxford (1)

Intervention

arbidol (3)

placebos (2)

lopinavir and ritonavir tablets (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

arbidol

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Coronavirus Infections Trial in Guangzhou (Lopinavir and Ritonavir Tablets, Arbidol)

Completed

Coronavirus Infections

Lopinavir and Ritonavir Tablets
Arbidol

Guangzhou, Guangdong, China

Guangzhou Eighth People's Hospital

Jun 29, 2020

COPD Patients Trial in Shenyang (Arbidol, Placebos)

Recruiting

COPD Patients

Arbidol
Placebos

Shenyang, Liaoning, China

Shenjing Hospital

Oct 10, 2019

Influenza Trial in Beijing (Arbidol, Placebos)

Unknown status

Influenza

Arbidol
Placebos

Beijing, Beijing, China

China-Japan Friendship Hospital

Jan 17, 2019